Drug Patent Watch
DECEMBER 26, 2022
[
Bio Pharma Dive
DECEMBER 30, 2022
An investigation by two House committees concluded the FDA failed to document all its meetings with Biogen, and shifted to consider an accelerated clearance on a “substantially abbreviated timeline &rdquo
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 27, 2022
The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions.
Fierce Pharma
DECEMBER 29, 2022
Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report. aarmstrong. Thu, 12/29/2022 - 14:42
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Drug Patent Watch
DECEMBER 26, 2022
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatch - Make Better Decisions.
Bio Pharma Dive
DECEMBER 29, 2022
The Phase 3 results showed the one-time treatment outperformed standard factor replacement in adults with the bleeding disorder, but suggest it may be less potent than CSL and UniQure’s rival therapy
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Phorum
DECEMBER 28, 2022
This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.
Pharmaceutical Commerce
DECEMBER 28, 2022
Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton.
Fierce Pharma
DECEMBER 29, 2022
After FDA's Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena. fkansteiner. Thu, 12/29/2022 - 09:30
Pharmaceutical Technology
DECEMBER 29, 2022
Inotersen sodium is a Antisense Oligonucleotide owned by Akcea Therapeutics, and is involved in 9 clinical trials, of which 5 were completed, and 4 are ongoing. ISIS-TTRRx is a transthyretin (TTR) protein inhibitor. Normal and mutant forms of TTR progressively accumulate in tissues in transthyretin amyloidosis hence impairing the tissue function.
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharma Phorum
DECEMBER 29, 2022
The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis.
Drug Patent Watch
DECEMBER 30, 2022
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Epi Hlth and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Epi Hlth drug RHOFADE appeared first on DrugPatentWatch - Make Better Decisions. Patent Added
Fierce Pharma
DECEMBER 27, 2022
Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma. kdunleavy. Tue, 12/27/2022 - 09:16
Pharmaceutical Technology
DECEMBER 29, 2022
Panobinostat is under clinical development by Secura Bio and currently in the Phase I and Phase II in clinical pathway.
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Pharma Phorum
DECEMBER 30, 2022
The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new survey of 200 GPs in the UK.
Pharmaceutical Commerce
DECEMBER 30, 2022
The latest people news happenings over the past month.
Fossil Remedies
DECEMBER 29, 2022
Since the pharma sector has performed remarkably well in the fast few decades and the future is also showing very good signs, it is quite natural that more and more people are entering the arena. There are many types of pharma businesses and one can choose any of them.
Pharmaceutical Technology
DECEMBER 29, 2022
Tecarfarin sodium is under clinical development by Cadrenal Therapeutics and currently in the Phase III in clinical pathway.
Pharma Phorum
DECEMBER 29, 2022
A new Data Protection and Digital Information Bill is currently being considered by UK ministers.
Drug Patent Watch
DECEMBER 29, 2022
[
Pharmaceutical Commerce
DECEMBER 29, 2022
With the new additions, CDMO expands its analytical testing and development services.
Pharmaceutical Technology
DECEMBER 29, 2022
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca ’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract, and lung cancers.
Pharma Phorum
DECEMBER 28, 2022
Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.
Drug Patent Watch
DECEMBER 29, 2022
[
Pharmaceutical Commerce
DECEMBER 27, 2022
How taking steps to incorporate data into all regulatory and labeling operations helps firms avoid retroactively planning to recapture information.
Pharmaceutical Technology
DECEMBER 28, 2022
Gilead Sciences and Jounce Therapeutics have amended their current license agreement for first-in-class immunotherapy, GS-1811 (formerly JTX-1811). The initial license agreement was signed in 2020.
Pharma Phorum
DECEMBER 28, 2022
Gilead Sciences must like what it has seen in a two-year-old partnership with Jounce Therapeutics for a CCR8-targeting cancer immunotherapy – it has just agreed to take full ownership of the programme.
Drug Patent Watch
DECEMBER 28, 2022
Annual Drug Patent Expirations for ZONISADE Zonisade is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There is one patent protecting…. The post New patent for Azurity drug ZONISADE appeared first on DrugPatentWatch - Make Better Decisions. Patent Added
XTalks
DECEMBER 29, 2022
The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic.
Pharmaceutical Technology
DECEMBER 27, 2022
This year, volatility resulting from the Russian war on Ukraine, residual uncertainty from the Covid-19 pandemic, and more led to fluctuating dynamics in the pharmaceutical space.
Pharma Phorum
DECEMBER 30, 2022
Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approach.
Drug Patent Watch
DECEMBER 27, 2022
Annual Drug Patent Expirations for TASCENSO+ODT Tascenso Odt is a drug marketed by Handa and is included in one NDA. There are three patents protecting this drug. This drug has…. The post New patent for HANDA drug TASCENSO ODT appeared first on DrugPatentWatch - Make Better Decisions. Patent Added
Fierce Pharma
DECEMBER 28, 2022
UCB's bimekizumab finally back on the FDA's review list after May rejection. zbecker. Wed, 12/28/2022 - 11:17
Pharmaceutical Technology
DECEMBER 26, 2022
LegoChem Biosciences and Amgen have signed a multi-target research collaboration and license agreement to develop antibody-drug conjugates (ADC).
Expert insights. Personalized for you.
52 
Let's personalize your content